How does stem cell therapy help Parkinson's disease?

MSCs provide neuroprotection for remaining dopamine-producing neurons, reduce neuroinflammation, release neurotrophic factors that support neural function, and may promote the growth of new neural pathways to compensate for dopaminergic loss.

Can stem cell therapy improve motor symptoms in Parkinson's?

Yes. Many patients experience improvements in tremor, rigidity, bradykinesia, and balance after MSC therapy. Studies show improvements in UPDRS motor scores and quality of life assessments.

When should Parkinson's patients consider stem cell therapy?

Earlier intervention generally yields better results, as there are more dopamine neurons to protect. However, patients at all stages can benefit from the neuroprotective and anti-inflammatory effects of MSC therapy.

What non-motor symptoms of Parkinson's improve with stem cells?

Patients often report improvements in sleep quality, cognitive function, mood, energy levels, and autonomic symptoms such as constipation and urinary function after MSC treatment.

Parkinson's Disease Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for Parkinson's disease. MSC treatments support dopamine-producing neurons, improve motor function, and help manage Parkinson's symptoms.

About Parkinsons Stem Cell Therapy in Istanbul

Stem cell therapy for Parkinson's disease at StemCell Longevita in Istanbul, Turkey provides neuroprotective support for dopamine-producing neurons, reduces neuroinflammation, and may slow the progression of this devastating neurodegenerative condition. Our mesenchymal stem cell (MSC) treatments offer hope for patients seeking to improve motor function, reduce tremors, and maintain quality of life beyond what conventional medications alone can achieve.

How Stem Cell Therapy Works for This Condition

Parkinson's disease results from the progressive loss of dopamine-producing neurons in the substantia nigra. MSC therapy addresses this through multiple mechanisms: releasing neurotrophic factors (GDNF, BDNF) that protect surviving dopaminergic neurons, reducing the chronic neuroinflammation that accelerates neuronal death, stimulating endogenous neural repair mechanisms, and improving cerebral blood flow. While MSCs do not directly replace lost neurons, they create a neuroprotective environment that slows further degeneration.

Who Is a Candidate?

Candidates include patients diagnosed with idiopathic Parkinson's disease at any Hoehn & Yahr stage, though earlier stages (I-III) typically show the strongest response. Patients experiencing motor fluctuations, medication wearing-off effects, or insufficient symptom control with levodopa/dopamine agonists may benefit particularly. Patients with Parkinson's-plus syndromes (MSA, PSP) are evaluated on a case-by-case basis.

Treatment Process at StemCell Longevita

After reviewing your neurological records and movement disorder assessments, you travel to Istanbul for a comprehensive evaluation including neurological exam and movement scoring. Treatment involves combined IV infusion and intrathecal injection of MSCs, maximizing delivery to the central nervous system. The protocol is designed to provide both systemic anti-inflammatory effects and targeted neuroprotection in the brain.

Expected Results & Recovery

Patients commonly report reduced tremor severity, improved rigidity and bradykinesia, better balance and gait, improved speech clarity, enhanced mood and cognitive function, and improved sleep quality. Motor improvements are typically noticed within 1-3 months, with progressive benefits continuing for 6-12 months. Many patients report reduced medication requirements.

Why Choose Turkey for Treatment?

Our neurological team has extensive experience with Parkinson's patients from around the world. Istanbul's advanced medical infrastructure provides comprehensive neurological evaluation and treatment at 60-80% lower cost than US or European centers.

Cost of Treatment

Parkinson's stem cell therapy packages start from €7,500, including combined IV + intrathecal MSC protocol, neurological assessment, movement disorder evaluation, hotel accommodation, VIP transfers, and 12-month follow-up.

Part of Our Neurological Conditions Treatment Cluster

Neurological Conditions — Treatment Cluster

Pillar: stem cell therapy for neurological conditions in Istanbul

Research & guides: stem cell therapy for cerebral palsy research | MSC treatment for autism spectrum disorder | stem cell therapy for stroke recovery in Turkey | MSC treatment for spinal cord injury rehabilitation

Frequently Asked Questions About Parkinson's Disease Stem Cell Therapy

How does stem cell therapy help Parkinson's disease?: MSCs provide neuroprotection for remaining dopamine-producing neurons, reduce neuroinflammation, release neurotrophic factors that support neural function, and may promote the growth of new neural pathways to compensate for dopaminergic loss.
Can stem cell therapy improve motor symptoms in Parkinson's?: Yes. Many patients experience improvements in tremor, rigidity, bradykinesia, and balance after MSC therapy. Studies show improvements in UPDRS motor scores and quality of life assessments.
When should Parkinson's patients consider stem cell therapy?: Earlier intervention generally yields better results, as there are more dopamine neurons to protect. However, patients at all stages can benefit from the neuroprotective and anti-inflammatory effects of MSC therapy.
What non-motor symptoms of Parkinson's improve with stem cells?: Patients often report improvements in sleep quality, cognitive function, mood, energy levels, and autonomic symptoms such as constipation and urinary function after MSC treatment.